Literature DB >> 6269253

The effect of first-dose doxorubicin on the cyclic nucleotide levels of the human myocardium.

D V Unverferth, R H Fertel, R L Talley, R D Magorien, S P Balcerzak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6269253     DOI： 10.1016/0041-008x(81)90145-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  5 in total

Review 1.  Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection?

Authors:  Douglas B Sawyer; Xuyang Peng; Billy Chen; Laura Pentassuglia; Chee Chew Lim
Journal:  Prog Cardiovasc Dis       Date:  2010 Sep-Oct       Impact factor: 8.194

2.  Adriamycin inhibits PTH-mediated but not PGE2-mediated stimulation of cyclic AMP formation in isolated bone cells.

Authors:  G Kohler; V Shen; W A Peck
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

3.  The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Authors:  Hagir B Suliman; Martha Sue Carraway; Abdelwahid S Ali; Chrystal M Reynolds; Karen E Welty-Wolf; Claude A Piantadosi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

4.  Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.

Authors:  Aurelia H M de Vries Schultink; Annelies H Boekhout; Jourik A Gietema; Artur M Burylo; Thomas P C Dorlo; J G Coen van Hasselt; Jan H M Schellens; Alwin D R Huitema
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-02-10       Impact factor: 2.745

5.  Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin.

Authors:  Enrico Gallo; Carlo Diaferia; Elisabetta Rosa; Giovanni Smaldone; Giancarlo Morelli; Antonella Accardo
Journal:  Int J Nanomedicine       Date:  2021-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.